Search Results 2581-2590 of 14819 for Venlafaxine

  1. Nausea and vomiting - Mayo Clinic

    A monthly period is bad enough. Add in painful menstrual cramps, and you may be cursing this thing called womanhood. How do you get relief? Mesenteric ...

  2. A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease - Mayo Clinic

    Structural MRI, electroencephalography (EEG), behavioral motor and cognitive assessments will be administered in individuals with suspected Lewy body disease or ...

  3. Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

    About this study. This randomized phase II trial studies how well ATR kinase inhibitor M6620 (M6620) and gemcitabine hydrochloride work compared to standard ...

  4. Patient Stories - John M. Wilkinson, M.D. - Mayo Clinic

    Your gift holds great power – donate today! ... Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.

  5. A pivotal study of derazantinib in patients with inoperable or advanced intrahepatic cholangiocarcinoma and FGFR2 gene fusions or FGFR2 gene mutations or amplifications - Mayo Clinic

    1 in subjects with inoperable or advanced intrahepatic cholangiocarcinoma (iCCA) whose tumors harbor FGFR2 gene fusions (by FISH performed by the central ...

  6. Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL) - Mayo Clinic

    The primary objective of this study is to determine the Maximum Tolerated Dose (MTD) for belinostat when combined with CHOP regimen and establish the ...

  7. News - Vlad C. Vasile, M.D., Ph.D. - Mayo Clinic

    Their crucial work saves lives every day. Let Mayo Clinic researchers know they're appreciated with a quick message.

  8. Patient Stories - Kevin L. Nelson, Ph.D. - Mayo Clinic

    Your gift holds great power – donate today! ... Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.

  9. A Study of Secukinumab Compared to Ustekinumab for Treatment of Patients with Plaque Psoriasis - Mayo Clinic

    The purpose of this study is to assess the long-term safety, tolerability, and effectiveness of secukinumab over ustekinumab for the treatment of patients who ...

  10. Simtuzumab (GS-6624) in the Treatment of Cirrhosis Due to NASH - Mayo Clinic

    This study is to evaluate the safety and efficacy of simtuzumab (GS-6624) in adults with compensated cirrhosis due to Non-Alcoholic Steatohepatitis (NASH). It ...